Invesco Ltd. Purchases 21,266 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Invesco Ltd. increased its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 6.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 346,120 shares of the company's stock after purchasing an additional 21,266 shares during the quarter. Invesco Ltd. owned approximately 1.91% of Addus HomeCare worth $43,386,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the business. Smartleaf Asset Management LLC increased its holdings in Addus HomeCare by 324.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after buying an additional 214 shares during the last quarter. Parkside Financial Bank & Trust raised its holdings in shares of Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after purchasing an additional 148 shares during the period. Meeder Asset Management Inc. acquired a new stake in Addus HomeCare in the 4th quarter valued at about $77,000. Harvest Fund Management Co. Ltd bought a new position in Addus HomeCare during the fourth quarter worth about $86,000. Finally, KBC Group NV grew its holdings in Addus HomeCare by 49.1% during the fourth quarter. KBC Group NV now owns 814 shares of the company's stock worth $102,000 after purchasing an additional 268 shares during the period. Institutional investors own 95.35% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. StockNews.com cut Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Stephens reaffirmed an "overweight" rating and set a $142.00 price target on shares of Addus HomeCare in a report on Wednesday, March 12th. Oppenheimer upped their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, January 24th. Macquarie restated an "outperform" rating and set a $129.00 target price on shares of Addus HomeCare in a research note on Thursday, February 27th. Finally, JMP Securities reiterated a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a research note on Tuesday. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $132.78.

Addus HomeCare Trading Up 0.8 %

Shares of NASDAQ:ADUS traded up $0.76 on Tuesday, reaching $98.04. 146,359 shares of the company's stock were exchanged, compared to its average volume of 164,740. Addus HomeCare Co. has a twelve month low of $87.88 and a twelve month high of $136.72. The company has a fifty day moving average of $98.76 and a 200-day moving average of $116.65. The company has a market capitalization of $1.78 billion, a price-to-earnings ratio of 22.43, a PEG ratio of 1.41 and a beta of 0.93.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). The company had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. As a group, equities research analysts forecast that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.